Inspiratory muscle training for adolescents with Familial Mediterranean Fever
Official title: Outcomes of Inspiratory Muscle Training in FMF Adolescents
Run by Cairo University · NCT07129538 · Data updated 2026-11-12
This trial will try a daily inspiratory muscle training program to see if it improves breathing strength, exercise tolerance, and fatigue in teenagers (ages 13–17) with Familial Mediterranean Fever who are taking colchicine.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 13 Years to 17 Years |
| Sex | All |
| Enrollment | 40 (estimated) |
| Sponsor | Cairo University Academic / other |
| Locations | 1 site (Giza, Dokki) |
| Status | Recruiting |
| Started | May 10, 2025 |
| Main results expected | September 15, 2025 |
| Study ends | September 15, 2025 |
| Registry record updated | August 19, 2025 |
| Trial ID | NCT07129538 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Teenagers aged 13–17 with a confirmed diagnosis of Familial Mediterranean Fever who are medically stable and taking colchicine, and who do not have the listed exclusion conditions, are ideal candidates.
✕Probably not a fit
Patients with significant cardiac, renal, liver, diabetes, or neurological disorders, those outside the 13–17 age range, or those unable to perform the breathing exercises are unlikely to receive benefit from this protocol.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
Adolescents with Familial Mediterranean Fever will be assigned to an inspiratory muscle retraining (IMR) group or a waitlist control, with 20 participants per group. The IMR group will perform two IMR sessions daily, five days per week, for eight weeks; each session consists of three sets of ten breathing cycles. Both groups will continue their prescribed colchicine treatment during the study. Outcomes will focus on changes in pulmonary function, exercise tolerance, and fatigue.
Why it matters
Potential benefit: If successful, the program could strengthen breathing muscles and improve exercise capacity and fatigue in adolescents with FMF.
How similar studies have gone: Inspiratory muscle training has shown benefits for respiratory muscle strength and exercise capacity in other respiratory and neuromuscular conditions, but its effects specifically in FMF adolescents are not well established.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * FMF adolecents * ages 13 -17 years * forty patients Exclusion Criteria: * cardiac problems * renal problems * liver problems * diabetes * brain problems
Where it's running
-
Faculty of physical therapy
Giza, Dokki, Egypt Recruiting
Study contacts
- Principal investigator: Ali MA Ismail, lecturer — Cairo University
- Study coordinator: Ali MA Ismail, lecturer
- Email: ali.mohamed@pt.cu.edu.eg
- Phone: 01005154209
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Canakinumab use in FMF and Still's disease patients across real-world care
This real-world study looks at how people with FMF or Still's disease who were treated with canakinumab fare over at least 6 months.
-
Mediterranean diet with or without aerobic exercise for women with familial Mediterranean fever and fatty liver
This trial will test whether adding regular aerobic exercise to a Mediterranean diet helps women with familial Mediterranean fever who have non-alcoholic fatty liver disease.
-
Whole-body vibration plus vitamin D for adolescent girls with familial Mediterranean fever
This project will try adding regular whole-body vibration sessions to vitamin D and usual colchicine for girls aged 13–17 with familial Mediterranean fever to see if it improves fitness, muscle strength, and bone mass.
-
Investigating the Role of Foods in Familial Mediterranean Fever Attacks
This study is trying to see if certain foods, like gluten and wheat, can trigger or worsen attacks in people with Familial Mediterranean Fever.
-
Using RPH-104 to prevent fever attacks in patients with Familial Mediterranean Fever who can't tolerate colchicine
This study is testing if RPH-104 can help adults with Familial Mediterranean Fever who can’t take colchicine by preventing their fever attacks over a long period.
-
Testing a new diagnostic tool for Familial Mediterranean Fever
This study is testing a new blood test to see if it can help doctors diagnose Familial Mediterranean Fever in people with certain gene mutations.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.